Hypertension Clinical Trial
Official title:
Strengthening Primary Healthcare Delivery for Diabetes and Hypertension in Eswatini: A Cluster-randomized Trial
The WHO-PEN@Scale project is a three-arm cluster-randomized trial that is investigating the population-level effects of a healthcare reform in Eswatini, which aims to strengthen primary care for diabetes and hypertension. Prior to the reform, healthcare for diabetes and hypertension was mostly provided through physician-led teams in hospital outpatient departments. The healthcare reform aims to strengthen the provision of nurse-led care for diabetes and hypertension in primary healthcare facilities and community health worker-led care for these conditions in the facilities' catchment areas. The reform will broadly be guided by the World Health Organization's "Package of Essential Noncommunicable Disease Interventions for Primary Health Care in Low-Resource Settings" (WHO-PEN). The trial will take place at 84 clusters (a primary healthcare facility and its catchment area) across the country.
Status | Recruiting |
Enrollment | 3500 |
Est. completion date | December 16, 2022 |
Est. primary completion date | December 16, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 40 Years and older |
Eligibility | Inclusion criteria for the outcome assessment (household survey): - Residing in one of the selected households - Age =40 years Exclusion criteria for the outcome assessment (household survey): - Pregnant - Inability to provide written informed consent |
Country | Name | City | State |
---|---|---|---|
Swaziland | Clinton Health Access Initiative | Mbabane |
Lead Sponsor | Collaborator |
---|---|
University Hospital Heidelberg | Amsterdam Institute for Global Health and Development, Clinton Health Access Initiative, Eswatini, Diabetes Swaziland, SWABCHA, Eswatini, Swiss Tropical & Public Health Institute, University of Eswatini, University of Göttingen |
Swaziland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Glycemic control (continuous) among adults with diabetes | Mean glycated haemoglobin (HbA1c) among adults aged 40 years and older with diabetes | 12 months | |
Primary | Systolic blood pressure among adults with hypertension | Mean systolic blood pressure among adults aged 40 years and older with hypertension | 12 months | |
Secondary | HbA1c among adults with diabetes or prediabetes | Mean glycated haemoglobin (HbA1c) among adults aged 40 years and older with diabetes or prediabetes | 12 months | |
Secondary | Glycemic control (binary) among adults with diabetes | The proportion of adults aged 40 years and older with diabetes who have an HbA1c less than 7.0% | 12 months | |
Secondary | Glycemic control (binary) among adults with diabetes or prediabetes | The proportion of adults aged 40 years and older with diabetes or prediabetes who have an HbA1c less than 7.0% | 12 months | |
Secondary | Awareness of one's diabetes diagnosis | The proportion of adults aged 40 years and older with diabetes who report to have been diagnosed with diabetes prior to the household survey | 12 months | |
Secondary | Awareness of one's diabetes or prediabetes diagnosis | The proportion of adults aged 40 years and older with diabetes or prediabetes who report to have been diagnosed with diabetes or prediabetes prior to the household survey | 12 months | |
Secondary | Probability of being treated for diabetes among adults with diabetes | The proportion of adults aged 40 years and older with diabetes who report to be taking medication for their diabetes | 12 months | |
Secondary | Probability of having been tested for diabetes among adults with diabetes | The proportion of adults aged 40 years and older with diabetes who report to have ever been tested for diabetes | 12 months | |
Secondary | Probability of having been tested for diabetes among adults with diabetes or prediabetes | The proportion of adults aged 40 years and older with diabetes or prediabetes who report to have ever been tested for diabetes | 12 months | |
Secondary | Probability of smoking among adults with diabetes, prediabetes, or hypertension | The proportion of adults aged 40 years and older with diabetes, prediabetes, or hypertension who report to be a current smoker | 12 months | |
Secondary | Time spent doing moderate- or vigorous-intensity exercise among adults with diabetes, prediabetes, or hypertension | The mean number of minutes in a typical week spent doing moderate- or vigorous-intensity exercise among adults aged 40 years and older with diabetes | 12 months | |
Secondary | Systolic blood pressure among adults with diabetes | Mean systolic blood pressure among adults aged 40 years and older with diabetes | 12 months | |
Secondary | Systolic blood pressure among adults with diabetes or prediabetes | Mean systolic blood pressure among adults aged 40 years and older with diabetes or prediabetes | 12 months | |
Secondary | Diastolic blood pressure among adults with diabetes | Mean diastolic blood pressure among adults aged 40 years and older with diabetes | 12 months | |
Secondary | Diastolic blood pressure among adults with diabetes or prediabetes | Mean diastolic blood pressure among adults aged 40 years and older with diabetes or prediabetes | 12 months | |
Secondary | Hypertension control (binary) among adults with hypertension | The proportion of adults aged 40 years and older with hypertension who have a systolic blood pressure <140 mm Hg and a diastolic blood pressure <90 mm Hg | 12 months | |
Secondary | Diastolic blood pressure among adults with hypertension | Mean diastolic blood pressure among adults aged 40 years and older with hypertension | 12 months | |
Secondary | Awareness of one's hypertension diagnosis | The proportion of adults aged 40 years and older with hypertension who report to have been diagnosed with hypertension prior to the household survey | 12 months | |
Secondary | Probability of being treated for hypertension among adults with hypertension | The proportion of adults aged 40 years and older with hypertension who report to be taking blood-pressure-lowering medication | 12 months | |
Secondary | Probability of having been tested for hypertension among adults with hypertension | The proportion of adults aged 40 years and older with hypertension who report to have ever had their blood pressure measured | 12 months | |
Secondary | Frequency of drinking alcohol in the past 12 months among adults with diabetes, prediabetes, or hypertension | The proportion of adults aged 40 years and older with diabetes, prediabetes, or hypertension who report to having drunk daily, 5-6 days per week, 3-4 days per week, 1-2 days per week, 1-3 days per month, less than once a month, or never over the past 12 months. | 12 months | |
Secondary | 21. Knowledge on diabetes and hypertension among adults with diabetes, prediabetes, or hypertension | The proportion of adults aged 40 years and older with diabetes, prediabetes, or hypertension who correctly responded to each individual question on diabetes and hypertension related knowledge. | 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |